Las anemias congénitas, un grupo de trastornos sanguíneos caracterizados por la incapacidad del cuerpo para producir glóbulos rojos sanos de manera eficiente, condicionan la vida de quienes las pad...
Read moreEl tratamiento, denominado terapia SV B – I, ha sido desarrollado con la plataforma Smart Delivery of Nutrients Technology (SDN), creada por la reconocida investigadora María José Alonso.
Read moreAugustine Therapeutics, focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enz...
Read moreThe round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial
Read moreLa compañía de innovación biotecnológica tiene como objetivo acabar de sufragar las pruebas piloto de su desarrollo Fluxus y adquirir fortaleza financiera para negociar con partners interesados en...
Read moreIt has been announced today the successful completion of a €30 million capital increase through the issuance of 12,765,958 new shares, priced at €2.35 per share. This pricing reflects a 15.44%
Read moreProceeds from the Series C will be deployed to finalize clinical validation and expedite the regulatory approval process of deepull’s UllCORE diagnostic system, which received Breakthrough Device De...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today reported financial results for the first quarter ended Marc...
Read moreReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced the successful closing of a $65 million Series A financing round. The...
Read moreThis financial contribution will enable the Catalan biotech company to advance the development of new drugs targeting therapeutic targets traditionally considered intractable, such as intrinsically di...
Read moreConducted in 39 hospitals in Spain with the scientific coordination of the CNIC and in partnership with Hospital Clínic-IDIBAPS, the DapaTAVI study is a milestone in cardiovascular research and could...
Read moreA team of researchers at IRB Barcelona demonstrates that aneuploid cells are actively eliminated by neighbouring cells through cell competition.
Read more